Interventions for the treatment of oral cancer: Surgical treatment

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2006, Pages

  Oliver, Richard J ^a   Clarkson, J E ^b   Conway, D ^b   Glenny, A M ^b   Macluskey, M ^b   Pavitt, S ^b   Sloan, P ^b   Worthington, H V ^b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; COST BENEFIT ANALYSIS; DATA ANALYSIS; DATA EXTRACTION; DISEASE FREE SURVIVAL; HEALTH HAZARD; HOSPITALIZATION; HUMAN; INFORMATION PROCESSING; INTERMETHOD COMPARISON; MORBIDITY; MOUTH CANCER; MULTIMODALITY CANCER THERAPY; OROPHARYNX CANCER; QUALITY CONTROL; QUALITY OF LIFE; RECURRENT DISEASE; REVIEW; SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 42749103409     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006205     Document Type: Review

References (28)

1. Batsakis JG. Surgical excision margins: a pathologist's perspective. Advances in Anatomic Pathology 1999;6(3):140-8.
2. Bjordal K, Kaasa S. Psychometric validation of the EORTC Core Quality of Life Questionnaire, 30-item version and a diagnosis-specific module for head and neck cancer patients. Acta Oncologica 1992;31(3):311-21.
3. Carew JF, Singh B, Shah JP. Cervical lymph nodes. In: ShahJP, JohnsonNW, BatsakisJG editor(s). Oral cancer. London: Martin Dunitz, 2003:215-49.
4. Day TA, Davis BK, Gillespie MB, Joe JK, Kibbey M, Martin-Harris B, et al. Oral cancer treatment. Current Treatment Options in Oncology 2003;4(1):27-41.
5. Deleyiannis FW, Weymuller EA Jr, Coltrera MD. Quality of life of disease-free survivors of advanced (stage III or IV) oropharyngeal cancer. Head & Neck 1997;19(6):466-73.
6. Faggiano F, Partanen T, Kogevinas M, Boffetta P. Socioeconomic differences in cancer incidence and mortality. In: KogevinasM, PearceN, SusserM, BoffettaP editor(s). Social inequalities and cancer. Lyon: IARC Scientic Publications No 138. International Agency for Research in Cancer, 1997.
7. Funk GF, Karnell LH, Robinson RA, Zhen WK, Trask DK, Hoffman HT. Presentation, treatment, and outcome of oral cavity cancer: a National Cancer Data Base report. Head & Neck 2002;24(2):165-80.
8. Garg M, Beitler JJ. Controversies in management of the neck in head and neck cancer. Current Treatment Options in Oncology 2004;5(1):35- 40.
9. Haddadin KJ, Soutar DS, Oliver RJ, Webster MH, Robertson AG, MacDonald DG. Improved survival for patients with clinically T1/T2, N0 tongue tumors undergoing a prophylactic neck dissection. Head & Neck 1999;21(6):517-25.
10. Haddadin KJ, Soutar DS, Webster MH, Robertson AG, Oliver RJ, MacDonald DG. Natural history and patterns of recurrence of tongue tumours. British Journal of Plastic Surgery 2000;53(4):279-85.
11. Hammerlid E, Bjordal K, Ahlner-Elmqvist M, Jannert M, Kaasa S, Sullivan M, et al. Prospective, longitudinal quality-of-life study of patients with head and neck cancer: a feasibility study including the EORTC QLQ-C30. Otolaryngology Head and Neck Surgery 1997;116(6 Pt 1):666-73.
12. Hassan SJ, Weymuller EA. Assessment of quality of life in head and neck cancer patients. Head & Neck 1993;15(6):485-96.
13. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]. In: The Cochrane Library, 3, 2005. Chichester, UK: John Wiley & Sons, Ltd.
14. Hindle I, Downer MC, Speight PM. The epidemiology of oral cancer. British Journal of Oral and Maxillofacial Surgery 1996;34(5):471- 6.
15. Hughes CJ, Gallo O, Spiro RH, Shah JP. Management of occult neck metastases in oral cavity squamous carcinoma. American Journal of Surgery 1993;166(4):380-3.
16. La Vecchia C, Tavani A, Franceschi S, Levi F, Corrao G, Negri E. Epidemiology and prevention of oral cancer. Oral Oncology 1997;33(5):302-12.
17. Macfarlane GJ, Zheng T, Marshall JR, Boffetta P, Niu S, Brasure J, et al. Alcohol, tobacco, diet and the risk of oral cancer: a pooled analysis of three case-control studies. Oral Oncology 1995;31B(3):181-7.
18. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. International Journal of Cancer 1999;80(6):827-41.
19. Parkin DM. Global cancer statistics in the year 2000. Lancet Oncology 2001;2(9):533-43.
20. Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analysis of the published literature for survival endpoints. Statistics in Medicine 1998;17(24):2815-34.
21. Partridge M, Li SR, Pateromichelakis S, Francis R, Phillips E, Huang XH, et al. Detection of minimal residual cancer to investigate why oral tumors recur despite seemingly adequate treatment. Clinical Cancer Research 2000;6(7):2718-25.
22. Pentenero M, Gandolfo S, Carrozzo M. Importance of tumor thickness and depth of invasion in nodal involvement and prognosis of oral squamous cell carcinoma: a review of the literature. Head & Neck 2005;27(12):1080-91.
23. Pignon J-P, Sylvester R, Bourhis J. Hyperfractionated and/or accelerated radiotherapy versus conventional radiotherapy for head and neck cancer (Protocol). In: Cochrane Database of Systematic Reviews, 2, 2000.
24. Robinson KL, Macfarlane GJ. Oropharyngeal cancer incidence and mortality in Scotland: are rates still increasing?. Oral Oncology 2003;39(1):31-6.
25. Shah JP. Cervical lymph node metastases - diagnostic, therapeutic, and prognostic implications. Oncology (Williston Park, NY) 1990;4(10):61-9.
26. WHO. ICD-O. International statistical classication of diseases and related health problems, 1989 revision. Geneva: World Health Organization, 1992.
27. Woolgar JA, Rogers SN, Lowe D, Brown JS, Vaughan ED. Cervical lymph node metastasis in oral cancer: the importance of even microscopic extracapsular spread. Oral Oncology 2003;39(2):130-7.
28. Xi S, Grandis JR. Gene therapy for the treatment of oral squamous cell carcinoma. Journal of Dental Research 2003;82(1):11-6.